2seventy bio to Announce Q1 2024 Financial Results on May 8, 2024

CAMBRIDGE, Mass.--2seventy bio, Inc. (Nasdaq: TSVT) is set to disclose its financial results for the first quarter of 2024 on Wednesday, May 8, 2024. The announcement will be accompanied by a conference call and webcast, scheduled for 8:00 a.m. ET.

Interested parties can attend the conference call live via a webcast, accessible through the Investors and Media section of the company's website. Those wishing to ask questions during the call may register in advance to obtain dial-in numbers and a unique pin for participation. Participants are advised to join the call 10 minutes before the scheduled start time. Additionally, a replay of the call will be available on the 2seventy bio website once the event concludes.

About 2seventy bio

The name 2seventy bio epitomizes the organization's commitment to combating cancer - TIME. Recognizing that cancer steals time from patients, the company aims to operate at the swift pace of 270 miles per hour, translating innovative ideas into actionable treatments to extend patients' lives. With a profound comprehension of the immune system's response to tumor cells and the practical application of cell therapies, 2seventy bio is leveraging its expertise to deliver the first FDA-approved CAR T cell therapy for multiple myeloma to as many patients as possible. The company emphasizes its mission by upholding authenticity and keeping its people and culture at the forefront of its efforts.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!